Lv4
670 积分 2023-01-22 加入
Complement inhibitors and B cell–modifying agents for IgA nephropathy—a Kidney Disease: Improving Global Outcomes (KDIGO) commentary
2天前
求助中
Iptacopan in IgA Nephropathy — Final 24-Month Data
3天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
3天前
已完结
Evidence from multicenter clinical studies and humanized mouse models indicates that glomerular mesangial IgA2 deposition contributes to the pathogenesis of IgA nephropathy
3天前
已完结
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
3天前
已完结
IgA nephropathy: a paradigm shift in treatment strategies
3天前
已完结
IgA Nephropathy in Adults
3天前
已完结
What do clinical trials teach us about the pathophysiology of human IgA nephropathy?
3天前
已完结
Deep learning-based transformation of H&E stained tissues into special stains
5天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
9天前
已完结
皖公网安备34019202002308
